Cerebrospinal fluid-glutamic oxalacetic acid transaminase in patients receiving electroconvulsive therapy and in neurologic diseases

Neurology ◽  
1960 ◽  
Vol 10 (4) ◽  
pp. 381-381 ◽  
Author(s):  
S. H. Mann ◽  
N. DePasquale ◽  
R. Paterson
2018 ◽  
Vol 77 (1) ◽  
pp. 13-22 ◽  
Author(s):  
Laura Kranaster ◽  
Carolin Hoyer ◽  
Suna S. Aksay ◽  
J. Malte Bumb ◽  
Norbert Müller ◽  
...  

Retrovirology ◽  
2015 ◽  
Vol 12 (S1) ◽  
Author(s):  
Yoshimi Enose-Akahata ◽  
Raya Massoud ◽  
Breanna Caruso ◽  
Joan Ohayon ◽  
Bridgette Jeanne Billioux ◽  
...  

Neurology ◽  
1956 ◽  
Vol 6 (12) ◽  
pp. 859-859 ◽  
Author(s):  
R. R. Apostol ◽  
E. Roboz ◽  
W. C. Hess ◽  
F. M. Forster

2002 ◽  
Vol 63 (3) ◽  
pp. 1178-1180 ◽  
Author(s):  
Sheldon Milstien ◽  
Naoki Sakai ◽  
Bruce J. Brew ◽  
Charles Krieger ◽  
James H. Vickers ◽  
...  

1991 ◽  
Vol 105 (2) ◽  
pp. 192-199 ◽  
Author(s):  
Milica Trbojevic-Cepe ◽  
Ivica Kracun ◽  
Anica Jusic ◽  
Ivan Pavlicek

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Lilibet Urias-Uribe ◽  
Emmanuel Valdez-Solis ◽  
Claudia González-Milán ◽  
Claudia Ramírez-Rentería ◽  
Aldo Ferreira-Hermosillo

We present the case of a patient with previous psychiatric illness, acutely exacerbated by thyroid storm due to Graves’ disease, in whom treatment with antipsychotics induced catatonia. These associations are extremely rare and may be confused with Hashimoto’s encephalopathy, especially in the presence of anti-thyroid antibodies in cerebrospinal fluid. The treatment consists in the control of the triggering disease (in this case the resolution of the thyrotoxicosis) and the use of benzodiazepines. However, in some cases, the resolution of psychiatric symptoms is partial and may require the use of electroconvulsive therapy.


Sign in / Sign up

Export Citation Format

Share Document